Fused quinoline derivatives useful as GABA modulators

Details for Australian Patent Application No. 2008264984 (hide)

Owner AstraZeneca AB

Inventors Herzog, Keith John; Dembofsky, Bruce Thomas; Chang, Hui-Fang; Schmiesing, Richard Jon; Chapdelaine, Marc; Horchler, Carey

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008264984

PCT Pub. Number WO2008/155572

Priority 60/944,879 19.06.07 US

Filing date 18 June 2008

Wipo publication date 24 December 2008

International Classifications

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/155572 Priority application(s): WO2008/155572

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008264985-Cinnoline compounds for use in the treatment of schizophrenia

2008264981-Water-stable catalysts for polyurethane manufacture